254 related articles for article (PubMed ID: 20675674)
1. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy.
Padeletti L; Arnar DO; Boncinelli L; Brachman J; Camm JA; Daubert JC; Hassam SK; Deliens L; Glikson M; Hayes D; Israel C; Lampert R; Lobban T; Raatikainen P; Siegal G; Vardas P; ; Kirchhof P; Becker R; Cosio F; Loh P; Cobbe S; Grace A; Morgan J; ;
Europace; 2010 Oct; 12(10):1480-9. PubMed ID: 20675674
[TBL] [Abstract][Full Text] [Related]
2. Management of cardiac electrical implantable devices in patients nearing the end of life or requesting withdrawal of therapy: review of the Heart Rhythm Society 2010 consensus statement.
Kramer DB; Ottenberg AL; Mueller PS
Pol Arch Med Wewn; 2010 Dec; 120(12):497-502. PubMed ID: 21178906
[TBL] [Abstract][Full Text] [Related]
3. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.
Marinskis G; van Erven L;
Europace; 2010 Aug; 12(8):1176-7. PubMed ID: 20663788
[TBL] [Abstract][Full Text] [Related]
4. ICD deactivation: review of literature and clinical recommendations.
Thanavaro JL
Clin Nurs Res; 2013 Feb; 22(1):36-50. PubMed ID: 22645402
[TBL] [Abstract][Full Text] [Related]
5. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association.
Wilkoff BL; Auricchio A; Brugada J; Cowie M; Ellenbogen KA; Gillis AM; Hayes DL; Howlett JG; Kautzner J; Love CJ; Morgan JM; Priori SG; Reynolds DW; Schoenfeld MH; Vardas PE; ; ; ; ; ; ;
Europace; 2008 Jun; 10(6):707-25. PubMed ID: 18480075
[No Abstract] [Full Text] [Related]
6. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
[TBL] [Abstract][Full Text] [Related]
7. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
8. Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults.
Niewald A; Broxterman J; Rosell T; Rigler S
J Med Ethics; 2013 Feb; 39(2):94-7. PubMed ID: 23139392
[TBL] [Abstract][Full Text] [Related]
9. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy.
Lampert R; Hayes DL; Annas GJ; Farley MA; Goldstein NE; Hamilton RM; Kay GN; Kramer DB; Mueller PS; Padeletti L; Pozuelo L; Schoenfeld MH; Vardas PE; Wiegand DL; Zellner R; ; ; ; ; ;
Heart Rhythm; 2010 Jul; 7(7):1008-26. PubMed ID: 20471915
[No Abstract] [Full Text] [Related]
10. [Key ethic discussions in hospice/palliative care].
Jusić A
Acta Med Croatica; 2008 Dec; 62(5):447-54. PubMed ID: 19382626
[TBL] [Abstract][Full Text] [Related]
11. Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.
Morgenweck CJ
Curr Opin Anaesthesiol; 2013 Apr; 26(2):171-5. PubMed ID: 23403711
[TBL] [Abstract][Full Text] [Related]
12. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
[TBL] [Abstract][Full Text] [Related]
13. [Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients. A critical literature analysis].
Ladwig KH; Ischinger NF; Ronel J; Kolb C
Herzschrittmacherther Elektrophysiol; 2011 Sep; 22(3):151-6. PubMed ID: 21769624
[TBL] [Abstract][Full Text] [Related]
14. Deactivation of automatic implantable cardioverter-defibrillators in hospice and home care patients at the end of life.
Kirk TW
Home Healthc Nurse; 2008; 26(7):431-7. PubMed ID: 18622221
[TBL] [Abstract][Full Text] [Related]
15. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.
England R; England T; Coggon J
J Med Ethics; 2007 Sep; 33(9):538-40. PubMed ID: 17761824
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular implanted electronic devices in people towards the end of life, during cardiopulmonary resuscitation and after death: guidance from the Resuscitation Council (UK), British Cardiovascular Society and National Council for Palliative Care.
Pitcher D; Soar J; Hogg K; Linker N; Chapman S; Beattie JM; Jones S; George R; McComb J; Glancy J; Patterson G; Turner S; Hampshire S; Lockey A; Baker T; Mitchell S;
Heart; 2016 Jun; 102 Suppl 7():A1-A17. PubMed ID: 27277710
[TBL] [Abstract][Full Text] [Related]
17. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
Waterhouse E; Ahmad F
Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
[TBL] [Abstract][Full Text] [Related]
18. ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life.
Strömberg A; Fluur C; Miller J; Chung ML; Moser DK; Thylén I
Pacing Clin Electrophysiol; 2014 Jul; 37(7):834-42. PubMed ID: 24483943
[TBL] [Abstract][Full Text] [Related]
19. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
[TBL] [Abstract][Full Text] [Related]
20. Withdrawing implantable defibrillator shock therapy in terminally ill patients.
Lewis WR; Luebke DL; Johnson NJ; Harrington MD; Costantini O; Aulisio MP
Am J Med; 2006 Oct; 119(10):892-6. PubMed ID: 17000222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
